Lucid Diagnostics Inc. Operating Lease Cost
Lucid Diagnostics Inc. (LUCD) reported Operating Lease Cost of $1.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-25
- Lucid Diagnostics Inc. operating lease, cost for fiscal 2025 was $1.04M, a 11.04% decline from fiscal 2024.
- Lucid Diagnostics Inc. operating lease, cost for fiscal 2024 was $1.17M, a 3.79% decline from fiscal 2023.
- Lucid Diagnostics Inc. operating lease, cost for fiscal 2023 was $1.21M, a 27.66% increase from fiscal 2022.
- Lucid Diagnostics Inc. operating lease, cost for fiscal 2022 was $951.00K.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $1.04M 10-K · filed 2026-03-25 |
| 2024-12-31 | $1.17M 10-K · filed 2026-03-25 |
| 2023-12-31 | $1.21M 10-K · filed 2025-03-24 |
| 2022-12-31 | $951.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |